These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29941194)

  • 1. Corrigendum to "Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations" [Bioorg. Med. Chem. 25 (2017) 6273-6285].
    Singh M; Kaur M; Singh N; Silakari O
    Bioorg Med Chem; 2018 Aug; 26(14):4360-4361. PubMed ID: 29941194
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369].
    Abdelall EKA; Abdelhamid AO; Azouz AA
    Bioorg Med Chem Lett; 2018 Feb; 28(4):839. PubMed ID: 29395977
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to 'Design and synthesis of Coenzyme A analogues as Aurora kinase A inhibitors: An exploration of the roles of the pyrophosphate and pantetheine moieties'. [Bioorg. Med. Chem. 28 (2020) 115740].
    Bellany F; Tsuchiya Y; Tran TM; Edith Chan AW; Allan H; Gout I; Tabor AB
    Bioorg Med Chem; 2021 Jun; 40():116106. PubMed ID: 33985868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].
    Maryanoff BE
    Bioorg Med Chem; 2002 Oct; 10(10):3367. PubMed ID: 12150884
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].
    Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives" [Bioorg. Med. Chem. 15 (2007) 2434-2440].
    Metwally K; Aly O; Aly E; Banerjee A; Ravindra R; Bane S
    Bioorg Med Chem; 2017 May; 25(9):2679. PubMed ID: 28341404
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation". [Bioorg. Chem. 94C (2019)].
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Bioorg Chem; 2020 Mar; 96():103563. PubMed ID: 32007720
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".
    Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors" [Bioorg. Med. Chem. 25 (2017) 5077-5083].
    Innocenti R; Lenci E; Menchi G; Pupi A; Trabocchi A
    Bioorg Med Chem; 2017 Dec; 25(24):6724-6725. PubMed ID: 29111366
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors" [Bioorg. Med. Chem. 27 (2019) 115147].
    Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
    Bioorg Med Chem; 2020 Feb; 28(4):115293. PubMed ID: 31892438
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents" [Bioorg. Med. Chem. 19 (2011) 5409-5419].
    Kumar A; Tripathi VD; Kumar P; Gupta LP; Akanksha ; Trivedi R; Bid H; Nayak VL; Siddiqui JA; Chakravarti B; Saxena R; Dwivedi A; Siddiquee MI; Siddiqui U; Konwar R; Chattopadhyay N
    Bioorg Med Chem; 2019 Sep; 27(17):3960-3961. PubMed ID: 31345744
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].
    Li P; Cai S; Zhao T; Xu L; Guan D; Li J; Zhou J; Zhang H
    Bioorg Med Chem Lett; 2022 Jan; 56():128502. PubMed ID: 34906405
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to 'Design, synthesis and in vitro study of densely functionalized oxindoles as potent α-glucosidase inhibitors' [Bioorg. Med. Chem. 26(18) (2018) 4996-5005].
    Luthra T; Naga Lalitha K; Agarwal R; Uma A; Sen S
    Bioorg Med Chem; 2018 Dec; 26(23-24):6153. PubMed ID: 30470596
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Metal-assisted synthesis of unsymmetrical magnolol and honokiol analogs and their biological assessment as GABA
    Rycek L; Puthenkalam R; Schnürch M; Ernst M; Mihovilovic MD
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1811. PubMed ID: 28718421
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Design, synthesis and biological evaluation of novel procaine derivatives for intravenous anesthesia" [Bioorg. Med. Chem. Lett. 60 (2022) 128587].
    Yin J; Zhao Y; He Q; Hai A; Peng Y; Zuo Z; Gao L; Song Z; Ke B
    Bioorg Med Chem Lett; 2022 Jul; 68():128765. PubMed ID: 35525630
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors" [Bioorg. Med. Chem. 40 (2021) 116186].
    Bu H; Yuan X; Wu H; Zhou J; Zhang H
    Bioorg Med Chem; 2022 Jan; 54():116578. PubMed ID: 34920926
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR" [Bioorg. Med. Chem. 23, 2015, 2767-2780].
    Basu D; Richters A; Rauh D
    Bioorg Med Chem; 2015 Aug; 23(15):5075. PubMed ID: 32689707
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].
    Tawfik HO; El-Moselhy TF; El-Din NS; El-Hamamsy MH
    Bioorg Med Chem; 2020 Jan; 28(2):115255. PubMed ID: 31862309
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].
    Tawfik HO; El-Moselhy TF; El-Din NS; El-Hamamsy MH
    Bioorg Med Chem; 2020 Oct; 28(19):115687. PubMed ID: 32826133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.